Quantcast

Latest Lactams Stories

2014-05-07 23:03:04

The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, NY (PRWEB) May 07, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that a group of medical researchers is seeking physician participation in a national registry that tracks the use of atypical antipsychotic medications in pregnant...

2014-05-06 20:24:09

The St. Louis personal injury lawyers at Meyerkord & Meyerkord, LLC are currently reviewing cases of patients who have suffered harm after taking the medication Risperdal. ST. LOUIS, May 6, 2014 /PRNewswire/ -- Meyerkord & Meyerkord, LLC is a full-service personal injury law firm dedicated to protecting the rights of victims and families who have suffered harm through no fault of their own. By utilizing their extensive experience and resources, the firm has successfully...

2014-05-06 16:32:22

Demonstrated significant efficacy in manic and depressive mood symptoms and psychosis, and improved patient functioning TITUSVILLE, N.J., May 6, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., today announced the results of the company's schizoaffective relapse prevention study of once-monthly atypical long-acting antipsychotic INVEGA(®) SUSTENNA(® )(paliperidone palmitate). The trial found INVEGA(®) SUSTENNA(®) met its primary endpoint of delayed time to and reduced risk of...

2014-05-05 08:29:33

First prospective, randomized clinical trial to reflect context of "real world" issues in treating schizophrenia, including recent incarceration and substance abuse TITUSVILLE, N.J., May 5, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., today announced the results of its landmark PRIDE (Paliperidone Palmitate Research In Demonstrating Effectiveness) trial. PRIDE is the first prospective, randomized clinical trial to compare schizophrenia medications within the context of many...

2014-05-05 08:28:42

MONTREAL, May 5, 2014 /CNW/ - Canadians living with schizophrenia now have a new option to help treat their disease. Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc. announce today that ABILIFY MAINTENA(TM) (aripiprazole for prolonged release injectable suspension), indicated for the maintenance treatment of schizophrenia in stabilized adult patients, is now commercially available for use in Canada. ABILIFY MAINTENA(TM) is the first product in Canada from the global...

2014-05-01 12:24:21

DUBLIN, Ireland, May 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/lttzkl/caprolactam) has announced the addition of the"Caprolactam (CPL): 2014 World Market Outlook and Forecast up to 2018" [http://www.researchandmarkets.com/research/lttzkl/caprolactam ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Global Caprolactam (CPL) Market Report 2014: Includes Four Year Forecast is an...

2014-04-30 23:21:01

Court documents indicate some men who filed Risperdal lawsuits involving gynecomastia allege they were forced to undergo liposuction or mastectomies to remove excess breast tissue, and suffered severe psychological and emotional distress, reports Wright & Schulte LLC. New York, NY (PRWEB) April 30, 2014 Wright & Schulte LLC, an experienced personal injury law firm representing plaintiffs in Risperdal gynecomastia lawsuits, notes that the First Judicial District Court of...

2014-04-29 23:20:17

Passages Malibu CEO issues comments on new research and potential health risks. Malibu, CA (PRWEB) April 29, 2014 The American Academy of Pain and Medicine issued a new report on March 6th that analyzed more than 3 billion visits by American to their primary care providers between 2002 and 2009. A subsequent analysis of those visits revealed that 12.6% were related to prescriptions for sedatives and narcotic painkillers. On average, the number of visits related to sedatives and...

2014-04-26 23:01:46

A Recent Decision by The Arkansas Supreme Court Not To Reconsider Risperdal Lawsuit Judgement In A Recent Medicaid Fraud Lawsuit Has Many Concerned Columbus, OH (PRWEB) April 26, 2014 The Risperdal lawsuit lawyers at Wright & Schulte LLC are concerned with the recent decision by the Arkansas Supreme Court not to reconsider its reversal of a $1.2 billion judgement against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc., the makers of the antipsychotic drug...

2014-04-25 23:02:33

The Firm is investigating Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia due to their use of the antipsychotic medication. New York, New York (PRWEB) April 25, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) that allege the antipsychotic medication caused men and boys to develop gynecomastia, or male breast growth, continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that the Arkansas Supreme Court has rejected a...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related